Principal Scientist - Chiesi

Publiceringsdatum: 2026-08-21

Är du intresserad av att jobba inom yrken med teknisk inriktning? Mpya Sci & Tech AB är på jakt efter en skicklig civilingenjör, forskning och utveckling, kemi och du kan vara rätt person för jobbet. Sök nu om du är intresserad av att arbeta heltid hos Mpya Sci & Tech AB under tills vidare. De letar just nu efter nya medarbetare.

Stockholm är platsen där denna position är ledig. Mpya Sci & Tech AB söker för närvarande efter ambitiösa individer som vill utvecklas i rollen som civilingenjör, forskning och utveckling, kemi. Kolla in deras ledig tjänst och se om du har vad som krävs för att bli en del av deras team. Sista ansökningsdagen till jobbet som civilingenjör, forskning och utveckling, kemi hos Mpya Sci & Tech AB är måndag den fjortonde september 2026.

---

Jobbannons

Do you want to shape the future of rare disease medicine? Chiesi Global Rare Diseases is seeking a Principal Scientist in Biologics to join our Discovery & Early Research team. This is a dedicated leadership role within biologics drug development — a unique opportunity to drive scientific strategy in a cutting-edge biologics program and help shape our GRD pipeline.

As the Early Research representative on global project core teams and Pipeline Strategy teams, you'll drive nonclinical strategy for biologics programs, from early research through candidate development. You'll work closely with non-clinical, clinical, CMC, and business development, lead research teams, and help define the direction of Chiesi GRD's pipeline - while building external partnerships and representing the company at conferences and in strategic collaborations.

Key responsibilities include

• Act as the Early Research representative to the global project Core Team, driving nonclinical project strategy and leading activities within biologics, from early research through candidate development
• Drive strategic research directions and influence pipeline decisions as a core member of a Therapeutic Area Global Pipeline Strategy Team, supporting the prioritization and development of the GRD’s pipeline
• Lead cross-functional teams and collaborate with diverse functions – including non-clinical, clinical, CMC and business development – to integrate early biologics research with development objectives
• Supervise multiple research teams and activities within a Therapeutic Area, and drive innovative research through the implementation of state-of-the-art techniques and technologies
• Contribute to business development and competitive evaluations by leveraging broad knowledge of diseases, treatment modalities, and products within a given Therapeutic Area

About you

You hold a PhD degree in a relevant field, combined with at least five years of industrial experience or a strong academic track record with a clear and solid background within biologics drug development. Preferably you have experience across multiple biologics treatment modalities (e.g. gene editing, gene therapy, recombinant proteins).

You have a solid foundation in general biochemistry as well as molecular and cellular biology, and hands-on experience in animal disease model generation, biopharmaceutical candidate production, analysis, and characterisation.

You have led non-clinical research project teams and have been exposed to strategic decision-making at Global Core or Project Team level. You are a dynamic individual who thrives in a scientific environment, spotting opportunities where others see obstacles and you are a strong communicator and networker who manages competing priorities with clarity and purpose.

 

Interested?

If you have questions regarding the role, contact Senior Recruitment Consultant Johan Östman at +46 (0)76 628 7891 or johan.ostman@mpyascitech.com. Please submit your application no later than 13th of September and note that we interview candidates continuously and the position may be filled before the last application date.

About Chiesi

Chiesi is a family-owned, research-focused international pharmaceutical company headquartered in Parma, with more than 7,500 employees worldwide. We have established a strong heritage in delivering innovative pharmaceutical solutions to people living with respiratory, cardiovascular, and rare diseases. Chiesi R&D sites are located in Italy, France, the US, Canada, China, the UK, and Sweden. As a B-corp certified benefit corporation, Chiesi is highly committed to sustainability and supporting society. For more information, please visit: www.chiesipharma.com

Chiesi Global Rare Diseases

Chiesi Global Rare Diseases (GRD), established in 2020 and headquartered in Boston, is focused on the research, development, and commercialisation of treatments and patient support services for rare and ultra-rare disorders. Chiesi GRD is now hiring both in Sweden and globally to support these programmes.